ProSolus Seeks Higher Utilization of Transdermal Drug Delivery Technology

Products and ProjectsBy ProSolus PharmaApril 27, 2017Leave a comment

ProSolus Seeks Higher Utilization of Transdermal Drug Delivery TechnologyParent company, Mission Pharmacal, expands commitment to patch technology with significant investments in manufacturing and commercial team. Transdermal patch production line at ProSolus, Inc. in Miami Juan Mantelle, ProSolus Chief Operating Officer and Chief Scientific Officer MIAMI, Fla. (April 25, 2017) – ProSolus, Inc. (“ProSolus”) is doubling…

LidoFlex

Products and ProjectsBy ProSolus PharmaSeptember 18, 2014Leave a comment

ProSolus, Inc. is proud to announce the upcoming launch of LidoFlex, developed in conjunction with Mission Pharmacal and Richmar. LidoFlex has a 4% Lidocaine concentration, which is the highest concentration available without a prescription.